WeTrials shared a post on X:
“The NRG Oncology BN007 trial investigated whether combining immunotherapy (ipilimumab + nivolumab) with radiation could improve outcomes for patients with MGMT-unmethylated glioblastoma, who typically don’t respond well to standard chemotherapy.
Results showed no improvement compared to the standard temozolomide treatment—median progression-free survival was actually slightly lower.
While disappointing, this trial adds valuable insights for future research.
Learn more.
Find Immunotherapy Clinical Trials.
Explore glioma clinical trials.”
More from WeTrials on OncoDaily.